Posted on 346 NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the publication of a study in the journal Nature Medicine that used NanoString’s GeoMx® Digital Spatial Profiler (DSP) and the new Whole Transcriptome Atlas (WTA) to profile sarcoma tissue. The research was led by a team from the Broad Institute in Cambridge, Massachusetts. The paper, entitled “Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma,” can be found here.(https://www.nature.com/articles/s41591-020-01212-6) Nature Medicine publishes first peer-reviewed study using GeoMx DSP with next generation sequencing readout. (Photo: Business Wire)